MYLAN INC. and its subsidiary, Mylan Pharmaceuticals Private Limited, launched the world's first Herceptin biosimilar in India.
ION SOLUTIONS selected Foundation Medicine as its preferred partner for comprehensive cancer genomic profiling services.
Twenty-six public health and medical organizations called on drug stores and other retailers to follow the example of CVS Caremark and end the sale of cigarettes and other tobacco products.
GRU CANCER CENTER received a commitment of $6 million from the Masters Tournament and Augusta National Golf Club through the Community Foundation for the Central Savannah River Area.
JENNIFER DOUDNA was named the winner of the Lurie Prize in the Biomedical Sciences by the Foundation for the NIH.
The 10th annual ST. JUDE THANKS AND GIVING CAMPAIGN raised more than $97 million last holiday season to support the St. Jude Children's Research Hospital, a projected increase of more than 31 percent over the previous year. Since 2004, the campaign has raised nearly $485 million.
NOVARTIS acquired CoStim Pharmaceuticals Inc., a portfolio company developing monoclonal antibody drugs, for an undisclosed amount. The acquisition was announced by MPM Capital and Atlas Venture.
ROSWELL PARK CANCER INSTITUTE will collaborate with GenomOncology to develop an informatics solution that enables the association of next-generation sequencing results with knowledge resources to define actionable mutations.
ROCHE SERVICIOS S.A., a Roche affiliate, and Cancer Genetics Inc. have entered into a three-year agreement to expand molecular diagnostic cancer testing in Central America and the Caribbean.
THE DUKE-NUS GRADUATE MEDICAL SCHOOL Singapore has partnered with ImaginAb Inc. to establish a joint corporate laboratory to develop new in vivo molecular imaging agents to study cancer biology and immune function.
